chevron_leftBack
As of 22 June 2026, Belluscura plc has a market cap of $3.97M USD, ranking #45339 globally and #1039 in the United Kingdom.
It ranks #4023 in the Healthcare sector, and #850 in the Medical Devices industry.
Key Stats
Market Cap
$3.97MUSD
3.01M GBP
Enterprise Value
$3.07MUSD
2.32M GBP
Revenue (TTM)
$1.89MUSD
1.43M GBP
EBITDA (TTM)
-$17.7MUSD
-13.37M GBP
Net Income (TTM)
-$19.44MUSD
-14.72M GBP
PS Ratio
2.1
PB Ratio
0.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Robert Rauker
open_in_new
Employees
35
Founded
2015
Website
belluscura.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 3.5% | 3.4% | -4.9% | -52% | -92% | -95% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
BELL
Belluscura PLC Ordinary Shares
ISIN: GB00BD3B8Z11
Shares Out.:
Shares Outstanding:
401.31M1
Shares Float:
264.068M2
|
0.7500 GBX |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Belluscura plc
Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
LSE: SN
|
$13.05B
328K%
9.88B GBP
|
21.8
|
|
LSE: CTEC
|
$5.61B
141K%
4.25B GBP
|
34.0
|
|
NASDAQ: LIVN
|
$3.22B
81K%
|
-
|
|
NASDAQ: NVCR
|
$1.38B
35K%
|
-
|
|
LSE: AMS
|
$713.43M
18K%
540.36M GBP
|
55.3
|
|
LSE: TSTL
|
$235.73M
6K%
178.54M GBP
|
22.9
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
4M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
4M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
4M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
3M%
|
34.7
|
|
NYSE: SYK
|
$120.69B
3M%
|
38.3
|
|
NYSE: MDT
|
$101.9B
3M%
|
22.2
|
chevron_leftBack